South Limburg

DSM accelerates Science Based GHG emissions reduction target to 50% by 2030

Retrieved on: 
Tuesday, August 3, 2021
DSM, South Limburg, Companies

The acceleration of its initial 30% reduction target is based on the strong progress over the past few years.

Key Points: 
  • The acceleration of its initial 30% reduction target is based on the strong progress over the past few years.
  • With this step-up DSM continues to be an ambitious climate leader in its sector and the updated target provides a firm foundation for DSM to achieve net-zero by 2050.
  • DSM's new increased target has been reviewed and approved by the Science Based Targets initiative(SBTi).
  • DSM holds a platinum sustainability medal from EcoVadis putting DSM in the top 1% of its industry.

DSM reports H1 2021 results

Retrieved on: 
Tuesday, August 3, 2021
DSM, South Limburg, Companies, Economy of the Netherlands

On 31 March 2021, DSM acquired the flavor and fragrance bio-based intermediates business of Amyris, Inc., extending its offerings in Personal Care & Aroma Ingredients.

Key Points: 
  • On 31 March 2021, DSM acquired the flavor and fragrance bio-based intermediates business of Amyris, Inc., extending its offerings in Personal Care & Aroma Ingredients.
  • On 1 April 2021, DSM closed the sale of DSM's Resins & Functional Materials business (including DSM Niaga, DSM Additive Manufacturing and the coatings activities of DSM Advanced Solar) to Covestro AG.
  • In H1 2021, DSM made significant progress on improving its environment impact.
  • DSM has also stepped up its broad inclusion and diversity efforts, supporting highly-motivated employee resource groups and improving female representation at the executive level in H1 2021.

DSM - repurchase of shares (14 - 15 June 2021)

Retrieved on: 
Thursday, June 17, 2021
DSM, South Limburg, Companies

HEERLEN, Netherlands, June 17, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has completed the repurchase of 800,000 of its own shares at an average price of 150.36.

Key Points: 
  • HEERLEN, Netherlands, June 17, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has completed the repurchase of 800,000 of its own shares at an average price of 150.36.
  • This repurchase, announced on 16 March 2021, covers the commitments for the final stock dividend2020.
  • Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living.
  • DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity.

DSM concludes early redemption of €500 million bond

Retrieved on: 
Wednesday, June 16, 2021
DSM, South Limburg, Companies

HEERLEN, Netherlands, June 16, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living,today announces the final Make-whole Redemption Amount in relation to the early redemption of the 500 million 1.375% bond maturing 26 September 2022, issued under Prospectus dated 24 March 2015 of Koninklijke DSM N.V. (ISIN: XS1293087703)(the "Notes").

Key Points: 
  • HEERLEN, Netherlands, June 16, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living,today announces the final Make-whole Redemption Amount in relation to the early redemption of the 500 million 1.375% bond maturing 26 September 2022, issued under Prospectus dated 24 March 2015 of Koninklijke DSM N.V. (ISIN: XS1293087703)(the "Notes").
  • Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living.
  • DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity.
  • DSM and its associated companies deliver annual net sales of about 10 billion with approximately 23,000 employees.

Brains Bioceutical Corp. Completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing

Retrieved on: 
Wednesday, June 16, 2021
Medical Supplies, Biotechnology, Alternative medicine, Professional services, Health, General Health, Other Natural Resources, Pharmaceutical, Agriculture, Natural Resources, Finance, DSM, South Limburg, Companies

Brains Bioceutical Corp. (Brains or the Company) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders.

Key Points: 
  • Brains Bioceutical Corp. (Brains or the Company) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders.
  • DSM Venturing, who acted as lead investor in this round, is the corporate venture arm of Royal DSM (DSM), a global, purpose led science-based company active in health, nutrition and sustainable living.
  • Del Morgan & Co. acted as Brains financial agent in respect to the capital raise.
  • To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry, said Brains' CEO & Chairman Rick Brar.

Brains Bioceutical Corp. completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing

Retrieved on: 
Wednesday, June 16, 2021
DSM, South Limburg, Companies

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (Brains or the Company) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders.

Key Points: 
  • VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (Brains or the Company) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders.
  • DSM Venturing, who acted as lead investor in this round, is the corporate venture arm of Royal DSM (DSM), a global, purpose led science-based company active in health, nutrition and sustainable living.
  • Del Morgan & Co. acted as Brains financial agent in respect to the capital raise.
  • To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry, said Brains' CEO & Chairman Rick Brar.

Mile High Labs and Royal DSM Announce Exclusive Strategic Partnership to Develop and Commercialize the Next Generation of Science-Backed Cannabinoid Consumer Products

Retrieved on: 
Tuesday, June 15, 2021
Product management, Articles, Human activities, DSM, South Limburg, Science and technology, Hemp, Brand, Innovation, Mobile High-Definition Link

The partnership creates a platform from which leading consumer products companies can innovate and deliver novel consumer goods with globally trusted, health-benefit driven ingredients.

Key Points: 
  • The partnership creates a platform from which leading consumer products companies can innovate and deliver novel consumer goods with globally trusted, health-benefit driven ingredients.
  • The relationship will also see MHL and DSM partner in the development of unique hemp-derived cannabinoid product solutions.
  • "In a time like no other, I am deeply proud to ink this exclusive strategic relationship," said Jonathan Hilley, Chief Executive Officer, Mile High Labs.
  • Their unmatched portfolio and mission-driven approach makes DSM one of the most important consumer companies in the world.

Mile High Labs and Royal DSM Announce Exclusive Strategic Partnership to Develop and Commercialize the Next Generation of Science-Backed Cannabinoid Consumer Products

Retrieved on: 
Tuesday, June 15, 2021
Product management, Articles, Human activities, DSM, South Limburg, Science and technology, Hemp, Brand, Innovation, Mobile High-Definition Link

The partnership creates a platform from which leading consumer products companies can innovate and deliver novel consumer goods with globally trusted, health-benefit driven ingredients.

Key Points: 
  • The partnership creates a platform from which leading consumer products companies can innovate and deliver novel consumer goods with globally trusted, health-benefit driven ingredients.
  • The relationship will also see MHL and DSM partner in the development of unique hemp-derived cannabinoid product solutions.
  • "In a time like no other, I am deeply proud to ink this exclusive strategic relationship," said Jonathan Hilley, Chief Executive Officer, Mile High Labs.
  • Their unmatched portfolio and mission-driven approach makes DSM one of the most important consumer companies in the world.

 DSM - repurchase of shares (7 - 11 June 2021)

Retrieved on: 
Tuesday, June 15, 2021
DSM, South Limburg, Companies

The total number of shares repurchased under this program since 3 May 2021 to date is 752,683 shares for a total consideration of 113 million.

Key Points: 
  • The total number of shares repurchased under this program since 3 May 2021 to date is 752,683 shares for a total consideration of 113 million.
  • Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living.
  • DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity.
  • DSM and its associated companies deliver annual net sales of about 10 billion with approximately 23,000 employees.

 DSM - repurchase of shares (31 May - 4 June 2021)

Retrieved on: 
Tuesday, June 8, 2021
DSM, South Limburg, Companies

The total number of shares repurchased under this program since 3 May 2021 to date is 686,227 shares for a total consideration of 103 million.

Key Points: 
  • The total number of shares repurchased under this program since 3 May 2021 to date is 686,227 shares for a total consideration of 103 million.
  • Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living.
  • DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity.
  • DSM and its associated companies deliver annual net sales of about 10 billion with approximately 23,000 employees.